Home Monitoring in Virginia

Journey Health & Lifestyle is a U.S.-based direct-to-consumer retailer specializing in lightweight mobility and assistive devices designed for seniors and individuals with limited mobility. The company manufactures and sells a comprehensive line of electric power chairs, mobility scooters, upright walkers, lift chairs, lift beds, and bathroom safety equipment. Primary product lines include the Journey Air Elite and Journey Air lightweight folding power chairs, the Journey Zoomer folding power chair, the Journey So Lite folding power scooter, the Journey Adventure scooter, the Perfect Sleep Chair, and upright walkers marketed as UpWalkers. All products emphasize portability, lightweight construction, and ease of use—many require no assembly and are designed for travel on planes, cruises, and vehicles. The company targets aging adults and mobility-challenged consumers seeking independence for daily activities and travel. Journey Health serves over 2 million customers and offers financing through Bread Pay, HSA/FSA pre-tax payment options, and a 21-day return window. The company operates from Richmond, Virginia, maintains U.S.-based customer support (888-404-1724), and advertises free shipping on orders over $700. No specific FDA 510(k), ISO, or CE certifications are listed on the site, though the company emphasizes U.S.-based manufacturing and design.

RiskWise Supplies LLC assembles and distributes curated health kits designed for individual and family preparedness, with a focus on respiratory health and travel-ready essentials. The company operates from an FDA-registered facility in Lorton, VA (facility number 3041850200) and specializes in pre-assembled kits combining over-the-counter medications, diagnostic testing, personal protective equipment, and symptom comfort supplies. Current product offerings include the Respiratory Shield Travel Kit (Individual) and Respiratory Shield Travel Kit (Family), each designed to address exposure risks during travel and crowded environments. The Individual kit contains N95 respirators, COVID-19/Flu A&B rapid diagnostic test, hand sanitizer, disinfecting wipes, disposable thermometers, acetaminophen-based cold/flu medication, throat lozenges, and immune support supplements. The Family kit scales these components to serve up to four individuals, including pediatric-appropriate items such as children's ibuprofen. All components are sourced from trusted U.S. distributors and manufacturers meeting federal health and safety standards. Kits are labeled with expiration dates based on the earliest-expiring regulated component (diagnostics and medications). RiskWise targets travelers, commuters, families, and preparedness-minded consumers; the company also supports bulk and wholesale distribution to businesses, schools, and clinics. The site indicates the company is undergoing a brand refresh. Kits are distributed domestically within the United States only.

Hollister Incorporated is a medical device and consumables manufacturer specializing in ostomy care, continence care, and critical care products. The company designs and markets a comprehensive portfolio of pouching systems, skin barriers, accessories, and intermittent catheters for patients with colostomies, ileostomies, urostomies, and neurogenic or overactive bladder conditions. Key product lines include the CeraPlus™ line of ostomy care products featuring ceramide-infused rings and pouches for peristomal skin health and security, and VaPro™ intermittent catheters featuring proprietary 100% No Touch Protection technology to prevent contamination during insertion and use. The company operates globally across North America, Europe, and Asia-Pacific markets, serving home care patients, hospital systems, and long-term care facilities. Hollister provides complementary services including Secure Start™ personalized patient support programs and educational resources through dedicated learning centers covering bladder health, intermittent catheterization, and management of neurological conditions. The company emphasizes product innovation focused on skin protection, infection prevention, and user confidence for patients managing chronic conditions requiring ongoing medical care.

Eyegaze Inc. manufactures eye-tracking communication and control devices for individuals with severe motor impairment, including those with locked-in syndrome, ALS, cerebral palsy, multiple sclerosis, muscular dystrophy, Rett syndrome, and spinal cord injuries. The flagship product, Eyegaze Edge®, is an eye-driven AAC (augmentative and alternative communication) device that enables users to communicate, browse the web, control their environment, and access computing applications through eye gaze tracking. The system features rapid 15-second calibration, integrated speech generation, email integration with major providers (Gmail, Outlook, AOL, Yahoo), Bluetooth/WiFi connectivity for cellular communication, environmental control via infrared and radio frequencies, and specialized software designed to minimize eye fatigue. Product variants include Eyegaze Edge Prime and Eyegaze Edge Encore, with optional Endurance Battery Pack and Edge Links computer access software. Eyeworld Software provides an accessible interface optimized for eye-gaze input. The company serves patients, speech-language pathologists (SLPs), healthcare providers, and insurance/VA/grant-funded purchasers. Eyegaze has established market presence with international adoption and positions itself as the device of choice among locked-in users and SLPs. The company supports multiple funding pathways including cash pay, insurance, VA benefits, and third-party payers.

NotAlVision Inc. is a digital health company specializing in remote patient monitoring services for retinal diseases, particularly age-related macular degeneration (AMD). The company develops home-based diagnostic devices operated by patients and AI-enabled data analysis platforms to extend eye disease management from traditional clinic settings into patients' homes. NotAlVision's platform addresses the unmet diagnostic need in ophthalmology by enabling real-time, automated analysis of patient testing data through proprietary AI algorithms. The company's approach aims to improve treatment outcomes by facilitating treatment decisions that align with each patient's disease activity timing rather than pre-scheduled clinic appointments. Key clinical focus areas include early detection of dry AMD progression to wet AMD, improving real-world wet AMD treatment outcomes, and optimizing treatment timing to reduce under-treatment. The platform connects patients and physicians 24/7 through a monitoring center and includes a suite of patient-operated home-based diagnostic devices. NotAlVision targets ophthalmology practices and retinal specialists seeking to improve patient engagement, diagnostic accuracy, and clinical outcomes in AMD management. The company combines precision medicine principles with telehealth capabilities to address the acute onset and unpredictable nature of retinal disease progression.